CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)

26.98 +0.93 (+3.57%) As of 02:30PM CST. Market open.

CSPC Innovation Pharmaceutical Co., Ltd.

No. 62 Zhangju Road
Luancheng District
Shijiazhuang 051430
China
86 311 6780 9843
https://www.xnwpharma.net

Sector(s): Consumer Defensive
Industry: Packaged Foods
Full-time employees: 1,887

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Feng Han	GM & Director	N/A	N/A	1974
Mr. Long Dai	Secretary & CFO	N/A	N/A	1992

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Corporate governance

CSPC Innovation Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.